NEURODEGENERATIVE DISEASE TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

1. Research Objectives and Assumptions

   • Research Objectives
   • Assumptions
   • Abbreviations

2. Market Purview

   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snapshot, By Indication Type
     • Market Snapshot, By Drug Type
     • Market Snapshot, By Geography
   • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

   • Market Dynamics
     • Rise in prevalence of neurodegenerative diseases
     • Stringent regulatory guidelines
     • Increase in demand for novel therapeutics
   • Impact Analysis
   • Key Highlights
   • Regulatory Scenario
   • Product launch/Approvals
   • PEST Analysis
   • PORTER’s Analysis
   • Merger and Acquisition Scenario

4. Global Neurodegenerative Disease Market, By Indication Type, 2021 - 2033, (US$ Mn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 – 2033
     • Segment Trends
   • Parkinson's Disease
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
   • Alzheimer's Disease
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
   • Multiple Sclerosis
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
   • Huntington Disease
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
   • Other Indication Types
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

5. Global Neurodegenerative Disease Market, By Drug Type, 2021 - 2033, (US$ Mn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 – 2033
     • Segment Trends
   • N-methyl-D-aspartate Receptor Antagonists
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
   • Cholinesterase Inhibitors
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
   • Dopamine Agonists
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
   • Immunomodulatory Drugs
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
   • Other Drug Types
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

6. Global Neurodegenerative Disease Market, By Geography, 2021 - 2033, (US$ Mn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 – 2033
     • Segment Trends
   • North America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
   • Europe
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
   • Asia Pacific
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
   • Latin America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
   • Middle East and Africa
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
   • Rest of World
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)

7. Competitive Landscape

   • Abbvie Inc.
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Amneal Pharmaceuticals Inc.
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Boehringer Ingelheim International Gmbh
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • F. Hoffmann-La Roche
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Merck & Co. Inc.
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Analyst Views

8. Section

   • Research Methodology
   • About us

*Browse 24 market data tables and 28 figures on "Global Neurodegenerative Disease Market” - forecast to 2033